Yang R, Cui J
Mol Cancer. 2024; 23(1):226.
PMID: 39385255
PMC: 11463124.
DOI: 10.1186/s12943-024-02141-5.
Smith N, Coleman C, Gewurz B, Rochford R
J Virol. 2020; 94(11).
PMID: 32238579
PMC: 7269432.
DOI: 10.1128/JVI.00428-20.
Platt J, Silva I, Balin S, Lefferts A, Farkash E, Ross T
JCI Insight. 2017; 2(9).
PMID: 28469081
PMC: 5414554.
DOI: 10.1172/jci.insight.90201.
Nakayama Y, Kim S, Kim E, Lambris J, Sandor M, Suresh M
J Immunol. 2009; 183(5):2921-31.
PMID: 19648268
PMC: 2753887.
DOI: 10.4049/jimmunol.0801191.
Ricklin D, Ricklin-Lichtsteiner S, Markiewski M, Geisbrecht B, Lambris J
J Immunol. 2008; 181(11):7463-7.
PMID: 19017934
PMC: 2673544.
DOI: 10.4049/jimmunol.181.11.7463.
The spectrum of Epstein-Barr virus-associated lymphoproliferative disease in Korea: incidence of disease entities by age groups.
Cho E, Kim K, Kim W, Yoo K, Koo H, Ko Y
J Korean Med Sci. 2008; 23(2):185-92.
PMID: 18436998
PMC: 2526432.
DOI: 10.3346/jkms.2008.23.2.185.
Complement evasion by human pathogens.
Lambris J, Ricklin D, Geisbrecht B
Nat Rev Microbiol. 2008; 6(2):132-42.
PMID: 18197169
PMC: 2814840.
DOI: 10.1038/nrmicro1824.
Complement-mediated activation of the adaptive immune responses: role of C3d in linking the innate and adaptive immunity.
Toapanta F, Ross T
Immunol Res. 2007; 36(1-3):197-210.
PMID: 17337780
DOI: 10.1385/IR:36:1:197.
Infection with an endemic human herpesvirus disrupts critical glial precursor cell properties.
Dietrich J, Blumberg B, Roshal M, Baker J, Hurley S, Mayer-Proschel M
J Neurosci. 2004; 24(20):4875-83.
PMID: 15152048
PMC: 6729472.
DOI: 10.1523/JNEUROSCI.5584-03.2004.
Complement: structure, functions, evolution, and viral molecular mimicry.
Mastellos D, Morikis D, Isaacs S, Holland M, Strey C, Lambris J
Immunol Res. 2003; 27(2-3):367-86.
PMID: 12857982
DOI: 10.1385/IR:27:2-3:367.
Epstein-Barr virus primes human polymorphonuclear leucocytes for the biosynthesis of leukotriene B4.
Gosselin J, Savard M, Tardif M, Flamand L, Borgeat P
Clin Exp Immunol. 2001; 126(3):494-502.
PMID: 11737068
PMC: 1906243.
DOI: 10.1046/j.1365-2249.2001.01687.x.
A Hodgkin's disease cell line, KM-H2, shows biphenotypic features of dendritic cells and B cells.
Uehira K, Amakawa R, Ito T, Uehira T, Ozaki Y, Shimizu T
Int J Hematol. 2001; 73(2):236-44.
PMID: 11372738
DOI: 10.1007/BF02981944.
Coreceptor restriction within the HLA-DQ locus for Epstein-Barr virus infection.
Haan K, Longnecker R
Proc Natl Acad Sci U S A. 2000; 97(16):9252-7.
PMID: 10908662
PMC: 16854.
DOI: 10.1073/pnas.160171697.
Biorecognition of HPMA copolymer-adriamycin conjugates by lymphocytes mediated by synthetic receptor binding epitopes.
Omelyanenko V, Kopeckova P, Prakash R, Ebert C, Kopecek J
Pharm Res. 1999; 16(7):1010-9.
PMID: 10450924
DOI: 10.1023/a:1018975414165.
Analysis of Epstein-Barr virus (EBV) receptor CD21 on peripheral B lymphocytes of long-term EBV- adults.
Jabs W, Paulsen M, Wagner H, Kirchner H, Kluter H
Clin Exp Immunol. 1999; 116(3):468-73.
PMID: 10361236
PMC: 1905320.
DOI: 10.1046/j.1365-2249.1999.00912.x.
Structure, functions, and evolution of the third complement component and viral molecular mimicry.
Sahu A, Sunyer J, MOORE W, Sarrias M, Soulika A, Lambris J
Immunol Res. 1998; 17(1-2):109-21.
PMID: 9479573
DOI: 10.1007/BF02786436.
Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome.
Lay J, Tsao C, Chen J, Kadin M, Su I
J Clin Invest. 1997; 100(8):1969-79.
PMID: 9329960
PMC: 508386.
DOI: 10.1172/JCI119728.
Infection of primary CD4+ and CD8+ T lymphocytes by Epstein-Barr virus enhances human immunodeficiency virus expression.
Guan M, Zhang R, Wu B, Henderson E
J Virol. 1996; 70(10):7341-6.
PMID: 8794395
PMC: 190801.
DOI: 10.1128/JVI.70.10.7341-7346.1996.
Intestinal epithelial cells express the CD23/Fc epsilon RII molecule: enhanced expression in enteropathies.
Kaiserlian D, Lachaux A, Grosjean I, Graber P, Bonnefoy J
Immunology. 1993; 80(1):90-5.
PMID: 8244467
PMC: 1422110.
Persistent Epstein-Barr virus infection in a human T-cell line: unique program of latent virus expression.
Yoshiyama H, Shimizu N, Takada K
EMBO J. 1995; 14(15):3706-11.
PMID: 7641689
PMC: 394445.
DOI: 10.1002/j.1460-2075.1995.tb00040.x.